Publications by authors named "Arran D Dokal"

Claim this Profile
P
Phosphoproteomics predict response to midostaurin plus chemotherapy in independent cohorts of FLT3-mutated acute myeloid leukaemia.
Weronika E Borek, Luis Nobre, S Federico Pedicona, Amy E Campbell, Josie A Christopher, Arran D Dokal

EBioMedicine· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational Analysis of Cholangiocarcinoma Phosphoproteomes Identifies Patient-Specific Drug Targets.
Shirin Elizabeth Khorsandi, Arran D Dokal, Vinothini Rajeeve, David J Britton, Megan S Illingworth

Cancer Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab and obinutuzumab differentially hijack the B cell receptor and NOTCH1 signaling pathways.
Jennifer Edelmann, Arran D Dokal, Emma Vilventhraraja, Karlheinz Holzmann, David Britton

iScience· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome instability is a consequence of transcription deficiency in patients with bone marrow failure harboring biallelic variants.
Hemanth Tummala, Arran D Dokal, Amanda Walne, Alicia Ellison, Shirleny Cardoso, Inderjeet Dokal

Proc Natl Acad Sci U S A· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis